Sub Heading

Clinical Trials Details

“A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, or Endometrial Adenocarcinoma, Based on Acrivon OncoSignature® Status”

IRB Protocol Number
ACR-368/GOG 3082

Clinical Trial Categories

  • Endometrial Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Women 18 years of age or older with confirmed Endometrial Adenocarcinoma w/Advanced Disease, Up to 3 Prior Lines of Therapy in the Recurrent Setting, Documented Failure for PD-1/PD-L1 based Therapy, Biopsy Required

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.